Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navdeep Pal

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BMC Cancer|April 18, 2023
Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world settingCristina Julian, Navdeep Pal, Anda Gershon, et al.
Frontiers in Pharmacology|February 12, 2024
Applying the estimand and target trial frameworks to external control analyses using observational data: a case study in the solid tumor settingLetizia Polito, Qixing Liang, Navdeep Pal, et al.
JTO Clinical and Research Reports|April 7, 2023
Real-World Comparative Effectiveness of First-Line Alectinib Versus Crizotinib in Patients With Advanced <i>ALK</i>-Positive NSCLC With or Without Baseline Central Nervous System MetastasesQing Zhang, Jessica J Lin, Navdeep Pal, et al.
Nature|April 8, 2021
Evaluating eligibility criteria of oncology trials using real-world data and AIRuishan Liu, Shemra Rizzo, Samuel Whipple, et al.
Nature Medicine|June 30, 2022
Systematic pan-cancer analysis of mutation-treatment interactions using large real-world clinicogenomics dataRuishan Liu, Shemra Rizzo, Sarah Waliany, et al.
Cell Reports. Medicine|March 1, 2024
Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 165,912 US patientsRuishan Liu, Lisa Wang, Shemra Rizzo, et al.
Gynecologic Oncology|July 12, 2014
Overall survival after pelvic exenteration for gynecologic malignancyShannon N Westin, Vijayashri Rallapalli, Bryan Fellman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2022
Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non-Small Cell Lung Cancer Trials Using Real-World DataThanh G N Ton, Navdeep Pal, Huong Trinh, et al.
The AAPS Journal|April 22, 2022
Machine Learning Prediction of Clinical Trial Operational EfficiencyKevin Wu, Eric Wu, Michael DAndrea, et al.
Gynecologic Oncology|May 4, 2017
Factors prognostic of survival in advanced-stage uterine serous carcinomaLaura L Holman, Navdeep Pal, David A Iglesias, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMC Cancer|April 18, 2023
Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world settingCristina Julian, Navdeep Pal, Anda Gershon, et al.
Frontiers in Pharmacology|February 12, 2024
Applying the estimand and target trial frameworks to external control analyses using observational data: a case study in the solid tumor settingLetizia Polito, Qixing Liang, Navdeep Pal, et al.
JTO Clinical and Research Reports|April 7, 2023
Real-World Comparative Effectiveness of First-Line Alectinib Versus Crizotinib in Patients With Advanced <i>ALK</i>-Positive NSCLC With or Without Baseline Central Nervous System MetastasesQing Zhang, Jessica J Lin, Navdeep Pal, et al.
Nature|April 8, 2021
Evaluating eligibility criteria of oncology trials using real-world data and AIRuishan Liu, Shemra Rizzo, Samuel Whipple, et al.
Nature Medicine|June 30, 2022
Systematic pan-cancer analysis of mutation-treatment interactions using large real-world clinicogenomics dataRuishan Liu, Shemra Rizzo, Sarah Waliany, et al.
Cell Reports. Medicine|March 1, 2024
Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 165,912 US patientsRuishan Liu, Lisa Wang, Shemra Rizzo, et al.
Gynecologic Oncology|July 12, 2014
Overall survival after pelvic exenteration for gynecologic malignancyShannon N Westin, Vijayashri Rallapalli, Bryan Fellman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2022
Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non-Small Cell Lung Cancer Trials Using Real-World DataThanh G N Ton, Navdeep Pal, Huong Trinh, et al.
The AAPS Journal|April 22, 2022
Machine Learning Prediction of Clinical Trial Operational EfficiencyKevin Wu, Eric Wu, Michael DAndrea, et al.
Gynecologic Oncology|May 4, 2017
Factors prognostic of survival in advanced-stage uterine serous carcinomaLaura L Holman, Navdeep Pal, David A Iglesias, et al.
Pageof 2